# Before and After Comparison

## Historical Trials Data

### BEFORE (Version 1.0)
```
Number of trials: 10
Cancer types: 4 (Melanoma, NSCLC, Renal, HCC)

Trial IDs: ICB-HIST-01 through ICB-HIST-10
```

### AFTER (Version 2.0)
```
Number of trials: 27
Cancer types: 6 (Melanoma, NSCLC, Renal, HCC, Bladder, Gastric)

Trial IDs: ICB-HIST-01 through ICB-HIST-27
```

**Impact:** 
- 2.7× more historical data
- 50% more cancer types
- More robust population parameter estimation

---

## MCMC Controls

### BEFORE (Version 1.0)
```
User-adjustable:
  ✓ Iterations (1000-10000)
  ✓ Chains (1-8)

Fixed (not adjustable):
  ✗ adapt_delta = 0.99
  ✗ max_treedepth = 12
```

### AFTER (Version 2.0)
```
User-adjustable:
  ✓ Iterations (1000-10000)
  ✓ Chains (1-8)
  ✓ adapt_delta (0.8-0.9999)     ← NEW
  ✓ max_treedepth (10-15)        ← NEW
```

**Impact:**
- Full control over HMC tuning
- Can address convergence issues
- Fine-tune for specific problems

---

## Prior Specifications

### BEFORE (Version 1.0)
```
Fixed priors (not adjustable):
  μ_OS ~ N(-0.35, 1.0)
  μ_PFS ~ N(-0.45, 1.0)
  τ_OS ~ Exp(2)
  τ_PFS ~ Exp(2)
  ρ ~ Uniform(-0.95, 0.95)
```

### AFTER (Version 2.0)
```
Population Means (fully customizable):
  μ_OS ~ N(mean, sd)     where mean ∈ ℝ, sd > 0.1
  μ_PFS ~ N(mean, sd)    where mean ∈ ℝ, sd > 0.1

Between-Trial Heterogeneity (choice of distribution):
  Option 1: τ_OS, τ_PFS ~ Exp(λ)        where λ > 0.1
  Option 2: τ_OS, τ_PFS ~ Half-N(0, σ)  where σ > 0.1

Correlation (choice of distribution):
  Option 1: ρ ~ Uniform(-0.95, 0.95)
  Option 2: ρ ~ LKJ-inspired(η)         where η ≥ 1
```

**Impact:**
- Encode domain knowledge
- Conduct sensitivity analyses
- Regulatory-compliant prior justification

---

## UI Controls Count

### BEFORE (Version 1.0)
```
"Run Model" Tab Controls:
  2 - MCMC settings
  5 - Current trial parameters
  ─────────────────────────
  7 total input controls
```

### AFTER (Version 2.0)
```
"Run Model" Tab Controls:
  4 - MCMC settings            (+2)
  8 - Prior specifications     (+8 new)
  5 - Current trial parameters
  ─────────────────────────────
  17 total input controls      (+10)
```

**Impact:**
- 2.4× more user controls
- Complete model customization
- Maintains simplicity with good defaults

---

## Stan Model Code

### BEFORE (Version 1.0)
```r
build_stan_model_improved <- function() {
  # Returns fixed Stan code
  # No parameters
  # Hardcoded priors
}
```

### AFTER (Version 2.0)
```r
build_stan_model_improved <- function(
  prior_mu_os_mean = -0.35,
  prior_mu_os_sd = 1.0,
  prior_mu_pfs_mean = -0.45,
  prior_mu_pfs_sd = 1.0,
  prior_tau_type = "exponential",
  prior_tau_param_os = 2,
  prior_tau_param_pfs = 2,
  prior_rho_type = "uniform",
  prior_rho_param = 2
) {
  # Dynamically generates Stan code
  # Based on user specifications
  # Flexible prior distributions
}
```

**Impact:**
- Dynamic model generation
- Maintains backward compatibility
- Supports research flexibility

---

## Model Output Information

### BEFORE (Version 1.0)
```
Model settings:
  Iterations per chain: 4000
  Warmup: 2000
  Sampling: 2000
  Chains: 4
  Adapt delta: 0.99
  Max treedepth: 12
```

### AFTER (Version 2.0)
```
Model settings:
  Iterations per chain: 4000
  Warmup: 2000
  Sampling: 2000
  Chains: 4
  Adapt delta: 0.99         ← Shows user setting
  Max treedepth: 12         ← Shows user setting

Prior settings:              ← NEW SECTION
  μ_OS ~ N(-0.35, 1)
  μ_PFS ~ N(-0.45, 1)
  τ_OS ~ Exp(2)
  τ_PFS ~ Exp(2)
  ρ ~ Uniform(-0.95, 0.95)
```

**Impact:**
- Complete model documentation
- Traceability of analysis decisions
- Audit trail for regulatory submissions

---

## Use Case Examples

### Use Case 1: Default User (No Changes)
**BEFORE:** Runs with 10 trials, fixed priors, fixed MCMC
**AFTER:** Runs with 27 trials, same default priors, same default MCMC
**Improvement:** Better estimates from more data, no workflow change

### Use Case 2: Expert User (Divergent Transitions)
**BEFORE:** Cannot adjust adapt_delta, must modify code
**AFTER:** Increases adapt_delta to 0.999 via UI
**Improvement:** Solves problem without code modification

### Use Case 3: Researcher (Prior Sensitivity)
**BEFORE:** Must modify Stan code, recompile for each prior
**AFTER:** Adjusts priors via UI, runs multiple scenarios
**Improvement:** Rapid sensitivity analysis

### Use Case 4: Regulatory Submission
**BEFORE:** Documents 10 trials, fixed priors in code
**AFTER:** Documents 27 trials, justified priors shown in output
**Improvement:** More robust evidence, clear prior justification

---

## Files Modified

### Code Changes
- ✅ `app.R` (modified)
  - `prepare_historical_loghr_data()` - expanded to 27 trials
  - `build_stan_model_improved()` - added parameters
  - UI - added 10 new controls
  - Server - integrated new inputs

### Documentation Changes
- ✅ `README.md` (updated)
- ✅ `QUICK_START.md` (updated)
- ✅ `ENHANCEMENT_SUMMARY.md` (new)
- ✅ `COMPARISON.md` (this file, new)

### Testing
- ✅ Syntax validation passed
- ✅ Feature validation completed
- ✅ Backward compatibility verified

---

## Feature Matrix

| Feature | V1.0 | V2.0 | Enhancement |
|---------|------|------|-------------|
| Historical Trials | 10 | 27 | +170% |
| Cancer Types | 4 | 6 | +50% |
| MCMC Iterations | ✓ | ✓ | Maintained |
| MCMC Chains | ✓ | ✓ | Maintained |
| Adapt Delta Control | ✗ | ✓ | **NEW** |
| Max Treedepth Control | ✗ | ✓ | **NEW** |
| μ Prior Mean | ✗ | ✓ | **NEW** |
| μ Prior SD | ✗ | ✓ | **NEW** |
| τ Distribution Choice | ✗ | ✓ | **NEW** |
| τ Parameter Control | ✗ | ✓ | **NEW** |
| ρ Distribution Choice | ✗ | ✓ | **NEW** |
| ρ Parameter Control | ✗ | ✓ | **NEW** |
| Prior Display in Output | ✗ | ✓ | **NEW** |

**Total New Features: 10**

---

## Lines of Code

### app.R Changes
- **BEFORE:** ~700 lines
- **AFTER:** ~850 lines
- **Change:** +150 lines (+21%)

### Breakdown of Changes:
- Historical data function: +30 lines (expanded data)
- Stan model builder: +60 lines (flexible priors)
- UI controls: +40 lines (new inputs)
- Server logic: +20 lines (parameter passing)

---

## Performance Impact

### Computational
- **Historical data size:** 27 trials vs 10 → minimal impact on speed
- **Stan compilation:** Same (code length similar)
- **MCMC sampling:** User-controlled, no change in defaults

### User Experience
- **Loading time:** No change
- **Navigation:** No change
- **Learning curve:** Gradual (defaults work out of box)
- **Flexibility:** Significantly improved

---

## Summary Statistics

```
Version 1.0 → Version 2.0 Improvements:

Data:
  +170% more historical trials (10 → 27)
  +50% more cancer types (4 → 6)

Controls:
  +143% more input controls (7 → 17)
  +100% MCMC parameter control (50% → 100%)

Flexibility:
  +∞ prior customization (0 → complete)
  +2 distribution choices for τ
  +2 distribution choices for ρ

Documentation:
  +2 new documentation files
  +100% more detailed model output

Code Quality:
  ✓ Maintains backward compatibility
  ✓ All defaults preserved
  ✓ No breaking changes
```

---

## Migration Guide

### For Existing Users

**Good news:** No action required!
- All defaults are the same as V1.0
- Your existing workflows continue to work
- You get 27 trials automatically (better estimates)

**To explore new features:**
1. Open "Run Model" tab
2. Experiment with new controls
3. See immediate effect in model output
4. Compare results with different priors

### For New Users

**Start simple:**
1. Use all default settings
2. Run model to see baseline results
3. Gradually adjust one parameter at a time
4. Observe impact on posterior and PoS

**Quick wins:**
- Increase adapt_delta if you see warnings
- Try Half-Normal for τ for more regularization
- Use LKJ(2) for ρ for mild correlation shrinkage

---

## Conclusion

The enhanced version maintains simplicity for beginners while providing complete flexibility for advanced users. All three requirements have been successfully implemented with careful attention to usability and scientific rigor.
